Introduction
============

In recent years, *Acinetobacter baumannii* (*A. baumannii*) has become a major nosocomial pathogen and frequent cause of hospital-acquired pneumonia, surgical wound infections and sepsis ([@b1-etm-0-0-3624]--[@b3-etm-0-0-3624]). The mortality of *A. baumannii*-VAP cases in critical care units is 42% ([@b2-etm-0-0-3624]), rendering *A. baumannii* a serious threat to ICU populations.

Toll-like receptors (TLRs), which belong to receptors of type I transmembrane proteins, were widely constitutively expressed in several cell types in lung tissue ([@b4-etm-0-0-3624],[@b5-etm-0-0-3624]). TLRs identified many types of pathogen-associated molecular patterns (PAMPs); transfer PAMP, such as LPS, into the cells through its transmembrane structure; produce complicated signaling cascade, which may induce the activation of nuclear factor-κB (NF-κB); induce the synthesis and release of a variety of inflammatory mediators; accelerate the elimination of *A. baumannii* by primary alveolar macrophages; and start the anti-apoptotic mechanism of lung epithelial cells ([@b6-etm-0-0-3624],[@b7-etm-0-0-3624]). TLR4 expression was downregulated by LPS isolated from multidrug-resistant *A. baumannii* by 0.6-fold ([@b8-etm-0-0-3624]). Additionally, through the establishment of a mouse model of *TLR4* gene knockout it was observed that the bacterial-killing ability against *A. baumannii* was impaired in TLR4-deficient bone marrow-derived macrophages (BMDMs) ([@b9-etm-0-0-3624],[@b10-etm-0-0-3624]). Thus, the physiological significance of TLR4 is to defend micro-organisms, and mediate innate immune responses, in which appropriate inflammation responses were useful in the defense of *A. baumannii*.

The mechanisms of the induced expression of TLR4 and the intensity of its signal transduction pathway have yet to be clarified. Smoking and high-dose LPS can enhance TLR4 expression of the alveolar macrophages ([@b11-etm-0-0-3624],[@b12-etm-0-0-3624]). In addition, the absence of endotoxin of *A. baumannii*, the circulatory disturbance of TLR4 receptors on the Golgi apparatus-cell membrane-lysosomal compartment of cells, and the effects of lung microenvironment on the subcellular localization of TLR4 may cause reduced TLR4 expression and the elimination of gram-negative bacillus ([@b13-etm-0-0-3624]--[@b15-etm-0-0-3624]). Thus, a different expression of TLR4 is associated with the cell type and state of bronchoalveolar and lung cells, the used reagents, and primers ([@b7-etm-0-0-3624]).

Clinically, patients with low immune function are particularly prone to *A. baumannii* infection, although the reason for this susceptibility remains to be determined. In ICU patients, because of the high prevalence of *A. baumannii* drug resistance, most *A. baumannii* infections result in severe bacterial infection, respiratory failure or multiple organ failure, with the mortality rate being equivalent to complex cardiovascular and cerebrovascular diseases ([@b2-etm-0-0-3624]). Thus, the constitutive and induced expression of TLR4 in immunocompromised patients with *A. baumannii* infection is to be investigated.

In the present study, an immunocompromised rat model with weakened phagocytic function of macrophage was established using hydrocortisone subcutaneous injection for 2 weeks, and the expression and changes of TLR4 in lung of rats with *A. baumannii* infection were observed. The role of the TLR4-NF-κB pathway in the pathogenesis and development of *A. baumannii* lung infection in immunocompromised hosts was then determined by detecting the expression of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in bronchoalveolar lavage. Control rats efficiently cleared *A. baumannii*, concurrent with the upregulated expression of TLR4 and a rapid elaboration of IL-6 and TNF-α in bronchoalveolar lavage and a corresponding mobilization of intrapulmonary neutrophils and macrophages. Immunocompromised rats deficient in TLR4 demonstrated a substantial delay in the clearance of *A. baumannii* with a decreased expression of IL-6 and TNF-α in bronchoalveolar lavage and a notable absence of intrapulmonary neutrophils and macrophages.

The aim of the present study was to determine the role of TLR4 in contributing to the identification of infection and signaling the innate immune response against *A. baumannii*.

Materials and methods
=====================

### Animal

In total, 72 healthy 6-week-old Sprague-Dawley male rats, weighing 150--180 g, were provided by the Institute of Pharmacology, Sichuan Academy of Traditional Chinese Medicine. The rats were randomly divided into cages at 25±0.5°C, and had access to common feed and drinking water *ad libitum*. The study was approved by the Animal Ethics Committee of Sichuan Second Hospital of Tradition Chinese Medicine with the approval code of 2014001.

### Experimental grouping

Fourteen days prior to the experiment, the rats were randomly divided into the control group (group with normal immune function, physiological saline was used in bronchial drip), infection group (group with normal immune function, *A. baumannii* suspension was used in bronchial drip), and immune-suppressed infection group (group with restrained immune function, *A. baumannii* suspension was used in bronchial drip) (n=24 rats per group). For the immune-suppressed infection group, hydrocortisone acetate (100 mg/kg) was subcutaneously injected every other day for 14 days prior to infection. Alveolar macrophage was collected after alveolar lavage to demonstrate weakened phagocytic function of alveolar macrophages. Thus, the rat model with immune-suppressed function was successfully proven. To avoid the development of an adrenal crisis, hydrocortisone acetate (100 mg/kg) was treated once a day for 7 days after *A. baumannii* infection.

### A. baumannii strains

Bacterial strains were isolated by the Department of Microbiology Laboratory, the Second Hospital of Traditional Chinese Medicine (Sichuan, China), from the sputum of a sepsis patient in the ICU. The strain belonged to pan drug-resistant *A. baumannii* for the conventional drug (all β-lactams, carbapenems and sulbactam, fluoroquinolones, aminoglycoside, polymyxin, tigecycline and colistin). Prior to the experiment, bacteria strains were cryopreserved in the refrigerator at −70°C. On the experiment day, *A. baumannii* were recovered with the conventional method, the bacterial suspension was inoculated with 2 µl and annulus on 35°C hydrolysis of casein agar plate (MH) was removed, placed in a constant temperature oscillation incubator (ShanghaiZhicheng Analytical Instrument Manufacturing Corporation, Shanghai, China), incubated for 18 h at 40 × g and 37°C, and then standardized to 1×10^8^ CFU/ml with sterile physiological saline.

### A. baumannii infection rat model

The rats were anesthetized using an intraperitoneal injection with 10% chloral hydrate (4 ml/kg). The animals were fastened on the operating table in a supine position, and neck skin preparation and disinfection were carried out, prior to exposing the trachea. One hundred microliters 1×10^8^ CFU/ml suspension of *A. baumannii* was dropped into the trachea. After tracheal instillation, the animals were maintained erect for 5 min, and then laid down until they became conscious. For the preliminary experiments, the right lower lung of rats was extracted directly for cultivating quantitatively to confirm that the model was successful.

### Collecting of lung tissue

The mental state, breathing, eating, drinking water, exercise, temperature, and fur of rats was observed daily and the survival rate was recorded. Two rats were randomly sacrificed with diethyl etheron on the 3rd and 7th day, and left lung tissue was bronchoalveolar lavaged with Hank\'s solution, 10 ml each time, 4 times in total. The superior lobe of right lung was collected to produce tissue homogenate, from which 10 µl was obtained for *A. baumannii* quantitative culture. The inferior lobe of the right lung was flushed 5 times with normal saline. Paraffin sections were fixed, dehydrated, and dewaxed in xylene, followed by paraffin-embedding and slicing using 4% polyformaldehyde. Hematoxylin and eosin (H&E) staining was subsequently carried out.

### H&E staining

Changes of lung tissue were observed under an optical microscope, and the semi-quantitative analysis of the lung tissue was carried out, using scoring criteria mentioned in [Table I](#tI-etm-0-0-3624){ref-type="table"}. Ten randomly selected high-power fields (×100) were observed on each lung tissue specimen, the score of each field was recorded, and the mean value was obtained.

### Immunohistochemistry

Integral optical density (IOD) values of positive cells in lung tissue were detected using Image-Pro Plus 6.0 image analysis system (Armonk, NY, USA). IOD values were used to reflect the expression of positive material in lung tissue.

### IL-6 and TNF-α were detected using enzyme-linked immunosorbent assay (ELISA)

Bronchoalveolar lavage fluid (BALF) was collected, and the levels of IL-6 and TNF-α were detected. The antibody sandwich method was used, and the kit was provided by Shanghai Jiang Lai Biotechnology Co., Ltd. (Shanghai, China).

### Statistical analysis

SPSS 13.0 software (Chicago, IL, USA) was used for statistical analysis. Lung bacterialoads were counted logarithmically for each experiment group and compared with the control group. Data were presented as mean ± standard deviation, and measurement data were expressed using one-way analysis of variance. The LSD method was used when variance was homogeneous, and the non-parametric rank-sum test was used when the variance was not homogeneous. P\<0.05 was considered statistically significant.

Results
=======

### H&E staining

H&E staining for the control group showed complete capillary bronchiole and alveolar structure, and trace amounts of inflammatory cell infiltration were observed in the early (3rd day) and late phase (7th day). In the *A. baumannii* infection group, at the earlier time points (3rd day), destructive capillary bronchiole and alveolar structure, widened bronchial and alveolar septum, a large number of inflammatory cells and lymph cell infiltration were observed. On the late 7th day, a large number of neutrophil infiltrations, unclear alveolar boundary, a fusion between the alveolar, disappeared alveolar structure and a large number of fibroblasts and extracellular matrix were observed. In the immune-suppressed infection group, at the early phase (3rd day), destructive alveolar structure, and pulmonary edema were observed without neutrophil or macrophage infiltration. In the late phase (7th day), neutrophil and macrophage infiltration, and partially restored alveolar structure were evident in capillary bronchus and alveolar. The pathological changes in the lung tissues of each group (H&E; magnification, ×100) are shown in [Fig. 1](#f1-etm-0-0-3624){ref-type="fig"}.

### Pneumonia score

The scores of the semi-quantitative analysis of the lung tissue at the different time points were determined ([Table II](#tII-etm-0-0-3624){ref-type="table"}). The result showed that compared with the control group, inflammation in the *A. baumannii* infection group in the early (the 3rd day) period was distinctly aggravated, and the pathological score (5.42±0.23) was higher (p\<0.001). By contrast, inflammation in the immune-suppressed infection group in the early (the 3rd day) period was obvious, and the pathological score (11.67±0.63) was increased (p\<0.001). Additionally, inflammation in the immune-suppressed infection group in the late (7th day) period was present, and the pathological score (8.92±0.514) was higher than those for the control and infection groups (p\<0.001).

### Immunohistochemical analysis of TLR4

TLR4 protein expression in lung of each group at different time points was examined ([Fig. 2](#f2-etm-0-0-3624){ref-type="fig"}). A mild TLR4 expression was observed in the bronchial epithelium and alveolar epithelial cell plasma of the control and infection groups, and the plasma was brown-stained and scattered. Compared with the control group, the number of macrophages in the early period of pulmonary infection was increased, and brown stained with particle aggregation. In addition, the expression of TLR4 was upregulated. The number of macrophages was rare in the late period of infection, and there was no significant difference in TLR4 expression compared with the control group, with the brown particles in the cells decreasing significantly. In the immune-suppressed infection group, bronchial epithelial and alveolar epithelial cells were yellow in the early period of pulmonary infection, and no alveolar macrophages and TLR4 expression were observed in the pulmonary tissue. In the late period, lung macrophages increased significantly, were brown stained with particle aggregation, and the expression of TLR4 improved. The expression and comparison of TLR4 protein of bronchial and lung tissues in each group are shown in [Fig. 3](#f3-etm-0-0-3624){ref-type="fig"}.

The comparison of the IOD values of TLR4 expression showed that in the early infection group (3rd day), the IOD value of TLR4 expression of lung tissue (0.78±0.08) ×10^4^ markedly increased compared with the control group, which had a statistically significant difference (p\<0.05). In the late infection group (7th day), compared with the control group, there was no significant improvement in the IOD value of TLR4 expression of lung tissue (0.46±0.09) ×10^4^, and there was no significant difference (p\>0.05). In the early immune-suppressed infection group (3rd day), the IOD value of TLR4 expression of lung tissue (0.23±0.08) ×10^4^ was lower than that in the control and infection groups, which had a statistically significant difference (p\<0.05). In the late immune-suppressed infection group (the 7th day), there was no significant difference between the IOD value of TLR4 expression of lung tissue (0.56±0.16) ×10^4^ and that in the control and infection groups (p\>0.05) ([Table III](#tIII-etm-0-0-3624){ref-type="table"}).

### A. baumannii count

In the early infection group (3rd day), the *A. baumannii* count after 24 h culture was 2.7±0.50 ×10^8^ CFU. In the late infection group (7th day), the *A. baumannii* count was 0.05±0.02 ×10^8^ CFU and there was no difference compared with that in the control group (the 7th day) ([Table IV](#tIV-etm-0-0-3624){ref-type="table"}).

In the early immune-suppressed infection group (3rd day), the *A. baumannii* count was 24.08±8.3 ×10^8^ CFU. In the late immune-suppressed infection group (7th day), the *A. baumannii* count was 2.58±0.51 ×10^8^ CFU, and the bacterial load capacity was significantly higher than that of the infection group (p\<0.001) ([Table IV](#tIV-etm-0-0-3624){ref-type="table"}).

### Levels of IL-6 and TNF-α of alveolar lavage fluid in each group at different time points

In the early infection group (3rd day), the content of IL-6 of the alveolar lavage fluid (733.92±12.48) markedly increased compared with the control group, which had a statistically significant difference (p=0.003). In the late infection group (7th day), the content of IL-6 of the alveolar lavage fluid (55.17±6.72) markedly increased compared with the control group, which had a statistically significant difference (p\<0.05) ([Table V](#tV-etm-0-0-3624){ref-type="table"}).

In the early immune-suppressed infection group (the 3rd day), the content of IL-6 of the alveolar lavage fluid (41.92±9.67) decreased significantly compared with the infection group, which had a statistically significant difference (p=0.003). In the late immune-suppressed infection group (7th day), the content of IL-6 of the alveolar lavage fluid (134.65±20.88) markedly increased compared with the infection group, which had a statistically significant difference (p=0.03) ([Table V](#tV-etm-0-0-3624){ref-type="table"}).

In the early infection group (3rd day), the content of TNF-α of the alveolar lavage fluid (203.33±33.35) markedly increased compared with the control group, which had a statistically significant difference (p\<0.001). In the late infection group (7th day), the content of TNF-α of the alveolar lavage fluid (39.5±11.63) markedly increased compared with the control group, which had a statistically significant difference ([Table VI](#tVI-etm-0-0-3624){ref-type="table"}).

In the early immune-suppressed infection group (3rd day), the content of TNF-α of the alveolar lavage fluid (5.0±1.63) decreased significantly compared with the infection group, which had a statistically significant difference (p\<0.001). In the late immune-suppressed infection group (7th day), the content of TNF-α of the alveolar lavage fluid (143.75±38.47) markedly increased compared with the infection group, which had a statistically significant difference ([Table VI](#tVI-etm-0-0-3624){ref-type="table"}).

Discussion
==========

In the present study, we demonstrated under the stimulation of *A. baumannii* that the expression of TLR4 was upregulated in the bronchial epithelial cells, neutrophils and alveolar macrophages. The secretion of IL-6 and TNF-α in BALF were increased, which activated more neutrophils and macrophages in lung to phagocytic bacteria. However, TLR4 expression of the lower respiratory tract in immunosuppressed rats was downregulated. In addition, the downregulated expression of TLR4 was accompanied with reduced IL-6 and TNF-α secretion and the reduced elimination of *A. baumannii* on the 3rd day after infection. In the subsequent recovery period, the expression of TLR4 was upregulated and the levels of IL-6 and TNF-α were increased.

The main modeling methods in the research of the lung infection of *A. baumannii* at home and abroad were: i) nose drip, or body was placed in a closed atomization generator, then an amount of aerosol particles were used to cause infection. This method cannot ensure successful inoculation. Additionally, bacteria entered in the lungs randomly and without uniformity; and ii) *A. baumannii* was dripped through endotracheal intubation, and when the dosage was established, uniformity of *A. baumannii* entering lung was also improved. However, this method requires the anesthesia of animals, and an increase in nursing work and mortality risk ([@b16-etm-0-0-3624],[@b17-etm-0-0-3624]). In the present study, *A. baumannii* suspension was applied through tracheal instillation and the right lower lung of rats was extracted directly for cultivating quantitatively to confirm that both the infection model and immune-suppressed rats model were successful. At the same time, the pathological results showed great inflammatory cell infiltration, pulmonary interstitial and alveolar edema, and hemorrhage on the third day after infection. Our results showed the general appearance of lung tissue, or using H&E staining, clear lung tissue inflammation, associated with an increase in the concentration of relevant inflammatory cytokines, such as TNF-α and IL-6, both present in BAL. With the extension of the infection time, the degree of inflammation was reduced, resulting in the decrease of *A. baumannii*.

We have shown that TLR4 protein in bronchial epithelial cells of rats was highly expressed in the cell membrane and cytoplasm in the infection group, and TLR4 protein in lung tissue was only expressed in cytoplasm of alveolar macrophages and a small amount of alveolar epithelial cells. Our immunohistochemical analysis revealed that, on the 3rd day of infection, TLR4 expression of alveolar macrophages was significantly increased compared with that in the control group, with statistical significance. On the 7th day of infection, with the ease of inflammation degree, TLR4 expression of alveolar macrophages was decreased, and there were no statistical differences compared with that in the control group. The results showed a high TLR4 expression of macrophages predicted good prognosis of *A. baumannii* pulmonary infection. This result is consistent with those of other studies which showed that the TLR4 receptor expression of macrophage in plasma of the patients after cardiac surgery decreased, potentially increasing the susceptibility of the *A. baumannii* infection ([@b10-etm-0-0-3624]).

Although this experiment was not involved in the study of macrophage TLR4 mRNA, other studies showed that *A. baumannii* induced the expression of macrophage TLR4 mRNA ([@b5-etm-0-0-3624]). *A. baumannii* with LPS deficiency failed to stimulate macrophages to release TNF-α, suggesting that TLR4 played an important role in the process of LPS-activated macrophage TLR4 expression and induced the TNF-α expression ([@b9-etm-0-0-3624]).

A number of common methods were employed in the establishment of immune-suppressed infection model: i) cyclophosphamide-treated, or diabetic rats were used; ii) cyclophosphamide in conjunction with hydrocortisone was used; iii) hydrocortisone was used alone ([@b16-etm-0-0-3624],[@b18-etm-0-0-3624]--[@b23-etm-0-0-3624]). The hydrocortisone model was used in this study, since single use of hydrocortisone decreased TLR4 expression of monocyte and the level of serum TNF-α and IL-1β, significantly delaying the elimination of bacteria ([@b22-etm-0-0-3624],[@b24-etm-0-0-3624],[@b25-etm-0-0-3624]).

Our results have shown that hydrocortisone-treated rats exhibit significantly increased bacterial burdens in the lungs, as well as more severe lung pathology compared with those in the control rats. Our findings have also shown that the expression of TLR4 protein was significantly decreased in the immune-suppressed rats with *A. baumannii* infection, together with a decrease in the expression of IL-6 and TNF-α. It is suggested that a decreased expression of TLR4 of alveolar macrophages in immune-suppressed rats may downregulate the bactericidal effect mediated by IL-6. On the other hand, when inoculated with *A. baumannii*, the immune-suppressed rats had a very small pulmonary inflammatory response with reduced inflammatory cells, although an obvious pulmonary edema in the lung appeared. We hypothesized that alveolar macrophage was the main effector cell on the over-activation of alveolar macrophages leading to the over-activation of NF-κB, which upregulated TLR4 expression, thus a positive feedback between TLR4 and NF-κB promotes acute lung injury. This speculation remain to be investigated in the future.

In conclusion, by studying the immunosuppressive rat model, TLR4 expression of *A. baumannii* in immune-suppressed rats decreased, alveolar macrophages were reduced, the secretion of IL-6 and TNF-α was reduced, and the phagocytic function of macrophage significantly was weakened, which indicated that a low expression of TLR4 and exacerbated *A. baumannii* infection mediated amplification, and resulted in aggravated *A. baumannii* infection and early death. Therefore, the enhanced expression of TLR4 protein in alveolar macrophages is a potential treatment for *A. baumannii* infection.

![H&E staining for the different groups. (A) Early control group (3rd day). (B) Late control group (7th day). (C) Early infection group (3rd day). (D) Late infection group (7th day). (E) Early immune-suppressed infection group (3rd day). (F) Late immune-suppressed infection group (7th day). H&E, hematoxylin and eosin. Original magnification, ×100.](etm-12-04-2599-g00){#f1-etm-0-0-3624}

![Immunohistochemistry for the different groups. (A) Early control group (3rd day). (B) Late control group (7th day). (C) Early infection group (3rd day). (D) Late infection group (7th day). (E) Early immune-suppressed infection group (3rd day). (F) Late immune-suppressed infection group (7th day). Original magnification, ×400.](etm-12-04-2599-g01){#f2-etm-0-0-3624}

![Immunohistochemistry of pulmonary alveoli for the different groups. (A) Early control group (3rd day). (B) Late control group (7th day). (C) Early infection group (3rd day). (D) Late infection group (7th day). (E) Early immune-suppressed infection group (3rd day). (F) Late immune-suppressed infection group (7th day). Original magnification, ×400.](etm-12-04-2599-g02){#f3-etm-0-0-3624}

###### 

The schedule of pneumonia score.

  Pathologic change                          0 scores             1 scores           2 scores      3 scores                4 scores
  ------------------------------------------ -------------------- ------------------ ------------- ----------------------- --------------------------
  Capillary blood clot                       No red blood cells                      Only little   More                    Almost full of the lumen
  The alveolar cavity fibrin exudation       No                                      Little        More                    Almost full of the lumen
  Neutrophilic exudate                       No                   Suspicious         Sporadic      Small focal exudation   Large area of seepage
  Airway mucosa epithelial cells decreased   No                   Suspicious                       Partial                 Large area
  Thickening of alveolar interval            Relatively normal    Slightly broaden                 Significant broaden     Loss of normal structure

###### 

Pathological scores of lung inflammation in each group (mean ± SD).

  Groups                        Early stage (3rd day)                                                                                     Late stage (7th day)
  ----------------------------- --------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------
  Control                       2.50±0.29                                                                                                 2.25±0.31
  Infection                     5.42±0.23^[a](#tfn2-etm-0-0-3624){ref-type="table-fn"}^                                                   3.083±0.260
  Immune-suppressed infection   11.67±0.63^[a](#tfn2-etm-0-0-3624){ref-type="table-fn"},\ [b](#tfn3-etm-0-0-3624){ref-type="table-fn"}^   8.92±0.514^[a](#tfn2-etm-0-0-3624){ref-type="table-fn"},\ [b](#tfn3-etm-0-0-3624){ref-type="table-fn"}^

Compared with the

control

infection group; both p\<0.001.

###### 

IOD value of TLR4 expression in each group (×10^4^) (mean ± SD).

  Groups                        Early stage (3rd day)                                                                                    Late stage (7th day)
  ----------------------------- -------------------------------------------------------------------------------------------------------- ----------------------
  Control                       0.46±0.08                                                                                                0.42±0.11
  Infection                     0.78±0.08^[a](#tfn4-etm-0-0-3624){ref-type="table-fn"}^                                                  0.46±0.09
  Immune-suppressed infection   0.23±0.08^[a](#tfn4-etm-0-0-3624){ref-type="table-fn"},\ [b](#tfn5-etm-0-0-3624){ref-type="table-fn"}^   0.56±0.16

Compared with the control group, p\<0.05.

Compared with the infection group, p\<0.05. Lung tissue *A. baumannii* load. IOD, integral optical density; TLR4, Toll-like receptor 4.

###### 

Count of the load capacity of *Acinetobacter baumannii* in lung tissue (×10^8^ CFU, median) (mean ± SD).

  Groups                        Early stage (3rd day)                                     Late stage (7th day)
  ----------------------------- --------------------------------------------------------- ---------------------------------------------------------
  Control                       0                                                         0
  Infection                     2.7±0.50                                                  0.05±0.02
  Immune-suppressed infection   24.08±8.3^[a](#tfn6-etm-0-0-3624){ref-type="table-fn"}^   2.58±0.51^[b](#tfn7-etm-0-0-3624){ref-type="table-fn"}^

Compared with the control group, p=0.03.

Compared with the infection group, p\<0.001.

###### 

Content of IL-6 in each group at different time points (mean ± SD).

  Groups                        Early stage (3rd day)                                        Late stage (7th day)
  ----------------------------- ------------------------------------------------------------ -------------------------------------------------------------
  Control                       12.19±3.61                                                   16.18±7.21
  Infection                     733.92±12.48^[a](#tfn9-etm-0-0-3624){ref-type="table-fn"}^   55.17±6.72^[b](#tfn10-etm-0-0-3624){ref-type="table-fn"}^
  Immune-suppressed infection   41.92±9.67^[c](#tfn12-etm-0-0-3624){ref-type="table-fn"}^    134.65±20.88^[d](#tfn12-etm-0-0-3624){ref-type="table-fn"}^

Compared with the control group

p=0.003

p\<0.001.

Compared with the infection group

p=0.03. IL-6, interleukin-6.

###### 

Content of TNF-α in each group at different time points (mean ± SD).

  Groups                        Early stage (3rd day)                                         Late stage (7th day)
  ----------------------------- ------------------------------------------------------------- -------------------------------------------------------------
  Control                       7.09±1.02                                                     4.33±0.72
  Infection                     203.33±33.35^[a](#tfn14-etm-0-0-3624){ref-type="table-fn"}^   39.5±11.63^[b](#tfn15-etm-0-0-3624){ref-type="table-fn"}^
  Immune-suppressed infection   5.0±1.63^[c](#tfn16-etm-0-0-3624){ref-type="table-fn"}^       143.75±38.47^[d](#tfn17-etm-0-0-3624){ref-type="table-fn"}^

Compared with the control group

p\<0.001

p=0.006. Compared with the infection group

p\<0.001

p=0.02. TNF-α, tumor necrosis factor-α.

[^1]: Contributed equally
